Dr. Celeste Cheryll Lopez Quianzon, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 46 Fairview Ave Ste 335, Skowhegan, ME 04976 Phone: 207-858-8216 Fax: 207-474-8089 |
News Archive
The oral diabetes medication metformin seems to reduce the chance of a late miscarriage and premature birth among women with polycystic ovary syndrome but does not affect their rate of developing gestational diabetes, a multicenter study finds.
Mersana Therapeutics, a platform-based cancer therapeutics company, today announced that it has entered into a research and exclusive license agreement with Teva Pharmaceutical Industries Ltd. to develop and commercialize XMT-1107, a novel fumagillin analog, for the treatment of all indications, including cancer.
A research team led by University of Arkansas chemist Jingyi Chen and University of Arkansas for Medical Sciences microbiologist Mark Smeltzer has developed an alternative therapeutic approach to fighting antibiotic-resistant infections.
A novel method of gene therapy is helping children born with a rare genetic disorder called AADC deficiency that causes severe physical and developmental disabilities.
The July issue of The American Journal of Medical Sciences presents a special symposium on the measurement and clinical implications of blood volume and its measurement.
› Verified 6 days ago